MS SIZA INTERNATIONAL products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Lahore · Pakistan
Lahore-based pharmaceutical manufacturer with domestic sales, marketing and export operations and production facilities on Ferozepur Road.
MS SIZA INTERNATIONAL products in Pakistan
MS SIZA INTERNATIONAL PVT LTD has 125 medicine presentations registered in Pakistan under 71 brands, covering 63 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and Fluids & supportive care. Its brands with the most registered strengths and packs are METROZIL (Metronidazole), CONVUL (Carbamazepine), PROPRANOLOL (Propranolol) and VEPROX (Ciprofloxacin). 125 products have an official DRAP price on MedInfoBase. See all 71 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- SIZA International (Private) Limited
- Company type
- Private pharmaceutical manufacturer
- Address
- 18-KM Main Ferozepur Road, Lahore 53000, Pakistan · 53000
- Website
- sizainternational.com ↗
- Phone
- +92 42 35401758; +92 42 35401759
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where MS SIZA INTERNATIONAL PVT LTD. is priced against the market
94 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| No matching products. | ||||||||
All 71 MS SIZA INTERNATIONAL brands in Pakistan
- ALOVAC Albendazole · 200 mg tablet
- AMRX Amlodipine · 10 mg tablet, 5 mg tablet
- AMYLINE Amitriptyline · 25 mg tablet
- AQUASIN Furosemide · 20 mg injection, 40 mg tablet
- ASMATOL Salbutamol · 0.5 mg injection
- ATHIOL Naloxone · 0.4 mg injection
- ATROVENT 1ml Atropine · 1 mg injection
- BIKIL Amikacin · 1 g injection, 250 mg injection, 500 mg injection
- BISON Bisoprolol fumarate · 10 mg tablet, 5 mg tablet
- BUGOMET Metformin · 1000 mg tablet, 500 mg tablet, 850 mg tablet
- CEPHAL Cephalexin · 250 mg capsule, 500 mg capsule
- CHLORAMPHENICOL Chloramphenicol · 250 mg tablet
- CLITHOR Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
- CLOPAN Metoclopramide · 10 mg tablet
- CLOPAN 2ml Metoclopramide · 10 mg injection
- CLOTRIMA Clotrimazole · 100 mg tablet, 500 mg tablet, 500 mg pessary
- CO-LISIN PLUS Lisinopril + Hydrochlorothiazide · 20 mg + 12.5 mg tablet
- CONVUL Carbamazepine · 200 mg tablet, 400 mg tablet
- COTRIZA Sulfamethoxazole, Sulfamethoxazole + Trimethoprim · 400 mg tablet, 800 mg + 160 mg tablet
- DEXAMETHASONE Dexamethasone · 0.5 mg tablet
- DUPOPHEN Fluphenazine decanoate · 25 mg/mL injection
- ELOVIR Aciclovir · 200 mg tablet
- ENERZA Iron protein succinylate · 800 mg/15 mL syrup, 800 mg/15 mL (equiv. 40 mg elemental iron) syrup, 800 mg/5 mL syrup
- EPINAT Phenytoin sodium · 100 mg tablet
- FERRUX Elemental Iron, Iron · 100 mg tablet, 50 mg/5 mL syrup
- FERRUX-F Iron polymaltose complex + Folic acid · 100 mg elemental iron + 0.35 mg folic acid tablet
- GLOSIFLOX Moxifloxacin · 400 MG tablet
- IBUPROFEN Ibuprofen · 200 mg tablet, 400 mg tablet
- KALSARTAN Losartan · 50 mg tablet
- KALSARTAN-H Losartan · 50 mg tablet
- Lacza Lactulose · 3.35 g/5 mL syrup
- LOMPER Omeprazole · 20 mg capsule
- LUMEZA Artemether · 80 mg/mL injection
- LUMEZA PLUS Artemether + Lumefantrine · 20 mg + 120 mg tablet, 40 mg + 240 mg tablet
- LYVOX Linezolid · 100 mg/5 mL suspension, 600 mg infusion, 600 mg tablet
- MAVEST Simvastatin · 10 mg tablet, 20 mg tablet
- MAYADIL RETARD Isosorbide dinitrate · 20 MG tablet
- METROZIL Metronidazole · 200 mg tablet, 200 mg/5 mL suspension, 400 mg tablet
- MYCOSIN Rifampicin · 450 MG tablet
- NAUSIN 50mg / ml Cyclizine Lactate · 50 mg injection
- NEOSTIG Neostigmine · 0.5 mg/mL injection, 2.5 mg injection
- NIFELAT Nifedipine · 10 mg tablet
- NOCTRUM Midazolam · 5 mg/5 mL injection
- NUMBAIX 25 mg Atracurium besylate · 25 mg/2.5 mL injection
- PARACETAMOL Paracetamol · 500 mg tablet
- PREDNISOLONE Prednisolone · 5 mg tablet
- PROCALM Chlorpromazine · 100 mg tablet
- PROGOUT Allopurinol · 300 mg tablet
- PROPRANOLOL Propranolol · 10 mg tablet, 40 mg tablet
- RANITIDE Ranitidine · 150 mg tablet, 50 mg/2 mL injection
- Siza InternationalDOX Doxycycline · 100 mg tablet
- SIZADOX Doxycycline · 100 mg tablet
- Sizle Water for Injection · 2 mL injection
- Sodium Chloride 0.9% Sodium chloride · 0.9 % injection, 0.9% infusion
- SOLVEIN 5% in NS Dextrose + Sodium chloride · 5% + 0.9% infusion
- SOLVEIN Dextrose 25% Dextrose · 25% infusion
- SOLVEIN Dextrose 5% Dextrose · 5% infusion
- SOLVEIN in Normal Saline Dextrose + Sodium chloride · NaCl 9g + Dextrose 5%/1000 mL infusion
- SOLVEIN RINGER LACTATE Water for Injection · 0.320 mg injection
- SOLVEIN RINGER'S USP Sodium chloride · 8.6 g injection
- Solvein-D Ringer Lactate-D Ringer's lactate solution · 0.2 g + 0.3 g + 6.0 g + 3.1 g + 50 g / 1000 mL infusion
- SOLVEIN-HYPER Dextrose · 5.61 g + 0.24 g + 0.15 g + 10.08 g (50% solution) + 77 g / 1000 mL infusion
- Solvein-Iso Dextrose · 5.61 g + 0.24 g + 0.15 g + 10.08 g (50% solution) + 16.5 g / 1000 mL infusion
- TRAUMAX Tranexamic acid · 250 mg/5 mL injection
- VEPROX Ciprofloxacin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg/5 mL suspension
- VITACIN Ascorbic acid · 100 mg tablet, 500 mg tablet
- VOTEC Levofloxacin · 250 mg tablet
- WORMAZOLE Mebendazole · 100 mg tablet
- XIVAL Cefixime · 100 mg/5 mL suspension, 400 MG capsule
- XIVAL-DS Cefixime · 200 mg/5 mL suspension
- ZINZA Azithromycin · 200 mg/5 mL suspension, 250 mg capsule
MS SIZA INTERNATIONAL: common questions
How many products does MS SIZA INTERNATIONAL have in Pakistan?
MS SIZA INTERNATIONAL PVT LTD has 125 registered medicine presentations in Pakistan, sold under 71 brands and covering 63 generic medicines.
What are the main brands of MS SIZA INTERNATIONAL?
By number of registered strengths and packs, its largest brands are METROZIL (Metronidazole), CONVUL (Carbamazepine), PROPRANOLOL (Propranolol), VEPROX (Ciprofloxacin) and AQUASIN (Furosemide). This is not a sales ranking.
Which therapy areas does MS SIZA INTERNATIONAL cover?
The most products are in Anti-infectives (44), Cardiovascular (21), Fluids & supportive care (12), CNS & mental health (10) and Gastrointestinal & hepatology (10).
Where can I see MS SIZA INTERNATIONAL medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.